Table 1 Evaluating MAOSS performance on staging liver steatosis and fibrosis between different CT modalities - NCCT and CECT (portal venous phase)

From: Multi-modal AI for opportunistic screening, staging and progression risk stratification of steatotic liver disease

CT Modality

AUROC

 

≤S1 vs ≥S2

F0-1 vs ≥F2

≤F2 vs ≥F3

≤F3 vs F4

NCCT

0.916 (0.850, 0.970)

0.835 (0.751, 0.897)

0.856 (0.776, 0.927)

0.901 (0.790, 0.986)

CECT

0.831 (0.755, 0.902)

0.829 (0.747, 0.894)

0.835 (0.754, 0.903)

0.880 (0.816, 0.936)

p-value

2.58e-04

0.292

0.007

0.007

  1. Delong tests were performed and a two-sided p value less than 0.05 was considered statistically significant between the compared modalities.
Back to article page